{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:54:08Z","timestamp":1791464048607,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"TUBITAK 2209\/A"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03450-z","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:00:44Z","timestamp":1791460844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of siRNA-mediated knockdown of the PD-L1 (CD274) gene on DUSP gene family expression and potential clinical implications in gastric cancer"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6462-7280","authenticated-orcid":false,"given":"Sinem","family":"Uykun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7913-8325","authenticated-orcid":false,"given":"Hakki","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7132-1325","authenticated-orcid":false,"given":"Ayca","family":"Tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3433-8870","authenticated-orcid":false,"given":"Tugba","family":"Agbektas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0292-4448","authenticated-orcid":false,"given":"Deniz Sahin","family":"Inan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7567-4681","authenticated-orcid":false,"given":"G\u00fclcihan \u00c7inar","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0562-7457","authenticated-orcid":false,"given":"Yavuz","family":"Silig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"6","key":"3450_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"3450_CR2","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1158\/1078-0432.CCR-10-2203","volume":"17","author":"MA Shah","year":"2011","unstructured":"Shah MA, Khanin R, Tang L, Janjigian YY, Klimstra DS, Gerdes H, Kelsen DP. Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res. 2011;17(9):2693\u2013701. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-2203.","journal-title":"Clin Cancer Res"},{"issue":"7517","key":"3450_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"AJ Bass","year":"2014","unstructured":"Bass AJ, Reynolds SM, Laird PW, Curtis C, Shen H, Weisenberger DJ, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202\u20139. https:\/\/doi.org\/10.1038\/nature13480.","journal-title":"Nature"},{"issue":"38","key":"3450_CR4","doi-asserted-by":"publisher","first-page":"64066","DOI":"10.18632\/oncotarget.19849","volume":"8","author":"Y Wu","year":"2017","unstructured":"Wu Y, Cao D, Qu L, Cao X, Jia Z, Zhao T, et al. PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer. Oncotarget. 2017;8(38):64066\u201379. https:\/\/doi.org\/10.18632\/oncotarget.19849.","journal-title":"Oncotarget"},{"key":"3450_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6573959","volume":"2020","author":"T Yun","year":"2020","unstructured":"Yun T, Wang S, Jiang B, Wang C, Meng N, Yuan X, Wang Y. Significance of detection of the HER2 gene and PD-1\/PD-L1 in gastric cancer. J Oncol. 2020;2020:1\u20139. https:\/\/doi.org\/10.1155\/2020\/6573959.","journal-title":"J Oncol"},{"key":"3450_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev.immunol.14.1.233","volume":"14","author":"DJ Lenschow","year":"1996","unstructured":"Lenschow DJ, Walunas TL, Bluestone JA. CD28\/B7 system of T cell costimulation. Annu Rev Immunol. 1996;14:233\u201358. https:\/\/doi.org\/10.1146\/annurev.immunol.14.1.233.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"3450_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2174\/187152212802001875","volume":"12","author":"T Liechtenstein","year":"2012","unstructured":"Liechtenstein T, Dufait I, Lanna A, Breckpot K, Escors D. Modulating co-stimulation during antigen presentation to enhance cancer immunotherapy. Immunol Endocr Metab Agents Med Chem. 2012;12(4):224\u201335. https:\/\/doi.org\/10.2174\/187152212802001875.","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"issue":"4","key":"3450_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13(4):227\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3450_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-065X.2009.00770.x","volume":"229","author":"CE Rudd","year":"2009","unstructured":"Rudd CE, Taylor A, Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev. 2009;229(1):12\u201326. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00770.x.","journal-title":"Immunol Rev"},{"issue":"6024","key":"3450_CR10","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science. 2011;331(6024):1565\u201370. https:\/\/doi.org\/10.1126\/science.1203486.","journal-title":"Science"},{"issue":"19","key":"3450_CR11","doi-asserted-by":"publisher","first-page":"12293","DOI":"10.1073\/pnas.192461099","volume":"99","author":"Y Iwai","year":"2002","unstructured":"Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A. 2002;99(19):12293\u20137. https:\/\/doi.org\/10.1073\/pnas.192461099.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3450_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.apsb.2020.07.010","volume":"11","author":"Z Song","year":"2021","unstructured":"Song Z, Wang M, Ge Y, Chen X-P, Xu Z, Sun Y, et al. Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies. Acta Pharm Sin B. 2021;11(1):13\u201329. https:\/\/doi.org\/10.1016\/j.apsb.2020.07.010.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"3450_CR13","doi-asserted-by":"publisher","first-page":"eaay4458","DOI":"10.1126\/sciadv.aay4458","volume":"6","author":"M Marasco","year":"2020","unstructured":"Marasco M, Berteotti A, Weyershaeuser J, Thorausch N, Sikorska J, Krausze J, et al. Molecular mechanism of SHP2 activation by PD-1 stimulation. Sci Adv. 2020;6(5):eaay4458. https:\/\/doi.org\/10.1126\/sciadv.aay4458.","journal-title":"Sci Adv"},{"key":"3450_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s42003-020-0845-0","volume":"3","author":"N Patsoukis","year":"2020","unstructured":"Patsoukis N, Duke-Cohan JS, Chaudhri A, Aksoylar H-I, Wang Q, Council A, et al. Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation. Commun Biol. 2020;3:128.","journal-title":"Commun Biol"},{"key":"3450_CR15","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41467-022-29845-8","volume":"13","author":"W Piao","year":"2022","unstructured":"Piao W, Li L, Saxena V, Iyyathurai J, Lakhan R, Zhang Y, et al. PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration. Nat Commun. 2022;13:2176. https:\/\/doi.org\/10.1038\/s41467-022-29845-8.","journal-title":"Nat Commun"},{"issue":"12","key":"3450_CR16","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1016\/j.celrep.2019.11.056","volume":"29","author":"SP Weisberg","year":"2019","unstructured":"Weisberg SP, Carpenter DJ, Chait M, Dogra P, Gartrell-Corrado RD, Chen AX, et al. Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1\/PD-L1 pathway. Cell Rep. 2019;29(12):3916\u2013e39285.","journal-title":"Cell Rep"},{"issue":"12","key":"3450_CR17","doi-asserted-by":"publisher","first-page":"9997","DOI":"10.1002\/jcb.27393","volume":"119","author":"H Li","year":"2018","unstructured":"Li H, Xia JQ, Zhu FS, Xi ZH, Pan CY, Gu LM, Tian YZ. LPS promotes the expression of PD-L1 in gastric cancer cells through NF-\u03baB activation. J Cell Biochem. 2018;119(12):9997\u201310004. https:\/\/doi.org\/10.1002\/jcb.27393.","journal-title":"J Cell Biochem"},{"issue":"9","key":"3450_CR18","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1182\/blood-2016-03-705699","volume":"128","author":"LC Chong","year":"2016","unstructured":"Chong LC, Twa DD, Mottok A, Ben-Neriah S, Woolcock BW, Zhao Y, et al. Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas. Blood. 2016;128(9):1206\u201313. https:\/\/doi.org\/10.1182\/blood-2016-03-705699.","journal-title":"Blood"},{"issue":"8","key":"3450_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41419-024-07264-1","volume":"15","author":"N Li","year":"2024","unstructured":"Li N, Zuo R, He Y, Gong W, Wang Y, Chen L, et al. PD-L1 induces autophagy and primary resistance to EGFR-TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway. Cell Death Dis. 2024;15(8):555. https:\/\/doi.org\/10.1038\/s41419-024-07264-1.","journal-title":"Cell Death Dis"},{"issue":"5","key":"3450_CR20","doi-asserted-by":"publisher","first-page":"e0156139","DOI":"10.1371\/journal.pone.0156139","volume":"11","author":"A Shuaib","year":"2016","unstructured":"Shuaib A, Hartwell A, Kiss-Toth E, Holcombe M. Multi-compartmentalisation in the MAPK signalling pathway contributes to the emergence of oscillatory behaviour and ultrasensitivity. PLoS ONE. 2016;11(5):e0156139. https:\/\/doi.org\/10.1371\/journal.pone.0156139.","journal-title":"PLoS ONE"},{"key":"3450_CR21","doi-asserted-by":"publisher","first-page":"1060497","DOI":"10.3389\/fimmu.2022.1060497","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yang Y, Chen Y, Lin W, Chen X, Liu J, et al. PD-L1: biological mechanism, function, and immunotherapy in gastric cancer. Front Immunol. 2022;13:1060497. https:\/\/doi.org\/10.3389\/fimmu.2022.1060497.","journal-title":"Front Immunol"},{"key":"3450_CR22","doi-asserted-by":"publisher","first-page":"107906","DOI":"10.1016\/j.intimp.2021.107906","volume":"98","author":"F Sun","year":"2021","unstructured":"Sun F, Yue TT, Yang CL, Wang FX, Luo JH, Rong SJ, et al. The MAPK dual-specific phosphatase (DUSP) proteins: a versatile wrestler in T-cell functionality. Int Immunopharmacol. 2021;98:107906. https:\/\/doi.org\/10.1016\/j.intimp.2021.107906.","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"3450_CR23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.bbamcr.2006.12.002","volume":"1773","author":"K Kondoh","year":"2007","unstructured":"Kondoh K, Nishida E. Regulation of MAP kinases by MAP kinase phosphatases. Biochim Biophys Acta Mol Cell Res. 2007;1773(8):1227\u201337. https:\/\/doi.org\/10.1016\/j.bbamcr.2006.12.002.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"Pt 22","key":"3450_CR24","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1242\/jcs.03266","volume":"119","author":"RJ Dickinson","year":"2006","unstructured":"Dickinson RJ, Keyse SM. Diverse physiological functions for dual-specificity MAP kinase phosphatases. J Cell Sci. 2006;119(Pt 22):4607\u201315. https:\/\/doi.org\/10.1242\/jcs.03266.","journal-title":"J Cell Sci"},{"issue":"3","key":"3450_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0092-8674(93)90384-F","volume":"75","author":"H Sun","year":"1993","unstructured":"Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate-early gene product, is a dual-specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 1993;75(3):487\u201393. https:\/\/doi.org\/10.1016\/0092-8674(93)90384-F.","journal-title":"Cell"},{"issue":"22","key":"3450_CR26","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1038\/sj.onc.1209351","volume":"25","author":"S Chattopadhyay","year":"2006","unstructured":"Chattopadhyay S, Machado-Pinilla R, Manguan-Garcia C, Belda-Iniesta C, Moratilla C, Cejas P, et al. MKP-1\/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer. Oncogene. 2006;25(22):3335\u201345. https:\/\/doi.org\/10.1038\/sj.onc.1209351.","journal-title":"Oncogene"},{"issue":"2","key":"3450_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0304-3835(03)00445-5","volume":"191","author":"HY Wang","year":"2003","unstructured":"Wang HY, Cheng Z, Malbon CC. Overexpression of mitogen-activated protein kinase phosphatases MKP-1, MKP-2 in human breast cancer. Cancer Lett. 2003;191(2):229\u201337. https:\/\/doi.org\/10.1016\/S0304-3835(03)00445-5.","journal-title":"Cancer Lett"},{"key":"3450_CR28","doi-asserted-by":"publisher","first-page":"110893","DOI":"10.1016\/j.cellsig.2023.110893","volume":"112","author":"F Zou","year":"2023","unstructured":"Zou F, Rao T, Chen W, Song T, Li T, Hu W, et al. DUSP2 affects bladder cancer prognosis by down-regulating MEK\/ERK and p38 MAPK signaling pathways through PTPN7. Cell Signal. 2023;112:110893. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110893.","journal-title":"Cell Signal"},{"issue":"5","key":"3450_CR29","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1172\/JCI43818","volume":"121","author":"SC Lin","year":"2011","unstructured":"Lin SC, Chien CW, Lee JC, Yeh YC, Hsu KF, Lai YY, Tsai SJ. Suppression of dual-specificity phosphatase-2 by hypoxia increases chemoresistance and malignancy in human cancer cells. J Clin Invest. 2011;121(5):1905\u201316. https:\/\/doi.org\/10.1172\/JCI43818.","journal-title":"J Clin Invest"},{"issue":"9","key":"3450_CR30","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/j.jid.2021.12.004","volume":"142","author":"H Kamada","year":"2022","unstructured":"Kamada H, Yasuhira S, Shibazaki M, Amano H, Maesawa C. DUSP4 inactivation leads to reduced ERK activity through upregulation of DUSP6 in melanoma cells. J Invest Dermatol. 2022;142(9):2499\u2013507. https:\/\/doi.org\/10.1016\/j.jid.2021.12.004.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"3450_CR31","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1038\/s41598-023-32684-9","volume":"13","author":"DH Yoo","year":"2023","unstructured":"Yoo DH, Im YS, Oh JY, Gil D, Kim YO. DUSP6 is a memory retention feedback regulator of ERK signaling for cellular resilience of human pluripotent stem cells in response to dissociation. Sci Rep. 2023;13(1):5683. https:\/\/doi.org\/10.1038\/s41598-023-32684-9.","journal-title":"Sci Rep"},{"key":"3450_CR32","doi-asserted-by":"publisher","first-page":"114478","DOI":"10.1016\/j.bbr.2023.114478","volume":"450","author":"NN Song","year":"2023","unstructured":"Song NN, Zhao Y, Sun C, Zhang J, Lin GJ, Yin XW, Ma CY. DUSP10 attenuates ischemic stroke-induced neuronal injury by restricting the p38\/JNK pathway. Behav Brain Res. 2023;450:114478. https:\/\/doi.org\/10.1016\/j.bbr.2023.114478.","journal-title":"Behav Brain Res"},{"issue":"28","key":"3450_CR33","doi-asserted-by":"publisher","first-page":"19949","DOI":"10.1074\/jbc.274.28.19949","volume":"274","author":"T Tanoue","year":"1999","unstructured":"Tanoue T, Moriguchi T, Nishida E. Molecular cloning and characterization of a novel dual-specificity phosphatase, MKP-5. J Biol Chem. 1999;274(28):19949\u201356. https:\/\/doi.org\/10.1074\/jbc.274.28.19949.","journal-title":"J Biol Chem"},{"key":"3450_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327. https:\/\/doi.org\/10.1016\/j.neo.2022.01.001.","journal-title":"Neoplasia"},{"issue":"3","key":"3450_CR35","doi-asserted-by":"publisher","first-page":"100532","DOI":"10.1016\/j.xinn.2024.100532","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov. 2024;5(3):100532. https:\/\/doi.org\/10.1016\/j.xinn.2024.100532.","journal-title":"Innov"},{"issue":"20","key":"3450_CR36","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor\u2013immune system interactions. Bioinformatics. 2019;35(20):4200\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btz210.","journal-title":"Bioinformatics"},{"issue":"6","key":"3450_CR37","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, et al. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45(6):580\u20135. https:\/\/doi.org\/10.1038\/ng.2653.","journal-title":"Nat Genet"},{"issue":"Suppl 2","key":"3450_CR38","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38(Suppl 2):W214\u201320. https:\/\/doi.org\/10.1093\/nar\/gkq537.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"3450_CR39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ng.3259","volume":"47","author":"CS Greene","year":"2015","unstructured":"Greene CS, Krishnan A, Wong AK, Ricciotti E, Zelaya RA, Himmelstein DS, et al. Understanding multicellular function and disease with human tissue-specific networks. Nat Genet. 2015;47(6):569\u201376. https:\/\/doi.org\/10.1038\/ng.3259.","journal-title":"Nat Genet"},{"issue":"W1","key":"3450_CR40","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3450_CR41","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3450_CR42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00210-019-01752-8","volume":"393","author":"PP Khin","year":"2020","unstructured":"Khin PP, Po WW, Thein W, Sohn UD. Apoptotic effect of fluoxetine through the endoplasmic reticulum stress pathway in the human gastric cancer cell line AGS. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(4):537\u201349. https:\/\/doi.org\/10.1007\/s00210-019-01752-8.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3450_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phymed.2018.04.008","volume":"46","author":"H Perumalsamy","year":"2018","unstructured":"Perumalsamy H, Sankarapandian K, Veerappan K, Natarajan S, Kandaswamy N, Thangavelu L, et al. In silico and in vitro analysis of coumarin derivative-induced anticancer effects via intrinsic apoptosis in human stomach cancer. Phytomedicine. 2018;46:119\u201330. https:\/\/doi.org\/10.1016\/j.phymed.2018.04.008.","journal-title":"Phytomedicine"},{"issue":"7","key":"3450_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/1062936X.2023.2234562","volume":"34","author":"HE Bostanc\u0131","year":"2023","unstructured":"Bostanc\u0131 HE, et al. Synthesis, biological evaluation and in silico studies of novel thiadiazole-hydrazone derivatives for carbonic anhydrase inhibitory and anticancer activities. SAR QSAR Environ Res. 2023;34(7):543\u201367. https:\/\/doi.org\/10.1080\/1062936X.2023.2234562.","journal-title":"SAR QSAR Environ Res"},{"issue":"1","key":"3450_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s13233-021-00977-3","volume":"30","author":"F S\u00f6zmen","year":"2022","unstructured":"S\u00f6zmen F, et al. Synthesis of multifunctional organic nanoparticles combining photodynamic therapy and chemotherapeutic drug release. Macromol Res. 2022;30(1):61\u20139. https:\/\/doi.org\/10.1007\/s13233-021-00977-3.","journal-title":"Macromol Res"},{"key":"3450_CR46","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.12659\/MSM.915246","volume":"25","author":"Z Tan","year":"2019","unstructured":"Tan Z. Recent advances in the surgical treatment of advanced gastric cancer: a review. Med Sci Monit. 2019;25:3537\u201345. https:\/\/doi.org\/10.12659\/MSM.915246.","journal-title":"Med Sci Monit"},{"issue":"3","key":"3450_CR47","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/hygiene3030020","volume":"3","author":"CD Iwu","year":"2023","unstructured":"Iwu CD, Iwu-Jaja CJ. Gastric cancer epidemiology: current trend and future direction. Hygiene. 2023;3(3):256\u201368. https:\/\/doi.org\/10.3390\/hygiene3030020.","journal-title":"Hygiene"},{"issue":"2","key":"3450_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s13304-020-00764-z","volume":"72","author":"A Agnes","year":"2020","unstructured":"Agnes A, Biondi A, Laurino A, Persiani R, D\u2019Ugo D. Global updates in the treatment of gastric cancer: a systematic review. Part 1: staging, classification and surgical treatment. Updates Surg. 2020;72(2):341\u201353. https:\/\/doi.org\/10.1007\/s13304-020-00764-z.","journal-title":"Updates Surg"},{"issue":"8","key":"3450_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11864-020-00769-2","volume":"21","author":"TH Patel","year":"2020","unstructured":"Patel TH, Cecchini M. Targeted therapies in advanced gastric cancer. Curr Treat Options Oncol. 2020;21(8):67. https:\/\/doi.org\/10.1007\/s11864-020-00769-2.","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"3450_CR50","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1159\/000458744","volume":"41","author":"J Li","year":"2017","unstructured":"Li J, Chen L, Xiong Y, Zheng X, Xie Q, Zhou Q, et al. Knockdown of PD-L1 in human gastric cancer cells inhibits tumor progression and improves cytotoxic sensitivity to CIK therapy. Cell Physiol Biochem. 2017;41(3):907\u201320. https:\/\/doi.org\/10.1159\/000458744.","journal-title":"Cell Physiol Biochem"},{"key":"3450_CR51","doi-asserted-by":"publisher","first-page":"106245","DOI":"10.1016\/j.intimp.2020.106245","volume":"82","author":"T Zhu","year":"2020","unstructured":"Zhu T, Hu Z, Wang Z, Ding H, Li R, Sun J, Wang G. Epigenetically silenced PD-L1 confers drug resistance to anti-PD-1 therapy in gastric cardia adenocarcinoma. Int Immunopharmacol. 2020;82:106245. https:\/\/doi.org\/10.1016\/j.intimp.2020.106245.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"3450_CR52","first-page":"705","volume":"48","author":"L Zhao","year":"2021","unstructured":"Zhao L, Zhao W, Feng Q, Zhao W, Zhang X, Jing W, Wei H. Effects of silencing PD-L1 expression on biological behaviors of gastric cancer cells. J Int Oncol. 2021;48(6):705\u201310.","journal-title":"J Int Oncol"},{"key":"3450_CR53","doi-asserted-by":"publisher","first-page":"134619","DOI":"10.1016\/j.molstruc.2023.134619","volume":"1275","author":"T Agbektas","year":"2023","unstructured":"Agbektas T, Zontul C, Ozturk A, Huseynzada A, Ganbarova R, Hasanova U, et al. Effect of azomethine group-containing compounds on gene profiles in Wnt and MAPK signaling patterns in lung cancer cell line: in silico and in vitro analyses. J Mol Struct. 2023;1275:134619. https:\/\/doi.org\/10.1016\/j.molstruc.2023.134619.","journal-title":"J Mol Struct"},{"issue":"13","key":"3450_CR54","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.3390\/cancers13133477","volume":"13","author":"E Sauta","year":"2021","unstructured":"Sauta E, Reggiani F, Torricelli F, Zanetti E, Tagliavini E, Santandrea G, et al. CSNK1A1, KDM2A, and LTB4R2 are new druggable vulnerabilities in lung cancer. Cancers (Basel). 2021;13(13):3477. https:\/\/doi.org\/10.3390\/cancers13133477.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"3450_CR55","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-7","volume":"30","author":"N Sunaga","year":"2001","unstructured":"Sunaga N, Kohno T, Kolligs FT, Fearon ER, Saito R, Yokota J. Constitutive activation of the Wnt signaling pathway by CTNNB1 (\u03b2-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer. 2001;30(3):316\u201321. https:\/\/doi.org\/10.1002\/1098-2264(2000)9999:9999%3C::AID-GCC1056%3E3.0.CO;2-7.","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"3450_CR56","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.bbrc.2009.10.049","volume":"390","author":"JS Britson","year":"2009","unstructured":"Britson JS, Barton F, Balko JM, Black EP. Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1\/2 signaling. Biochem Biophys Res Commun. 2009;390(3):849\u201354. https:\/\/doi.org\/10.1016\/j.bbrc.2009.10.049.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"3450_CR57","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3892\/or.2018.6518","volume":"40","author":"F Teng","year":"2018","unstructured":"Teng F, Xu Z, Chen J, Zheng G, Lv H, Cheng X, et al. DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer. Oncol Rep. 2018;40(3):1203\u201322. https:\/\/doi.org\/10.3892\/or.2018.6518.","journal-title":"Oncol Rep"},{"issue":"11","key":"3450_CR58","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1158\/1078-0432.CCR-03-0338","volume":"10","author":"S Vicent","year":"2004","unstructured":"Vicent S, Garayoa M, L\u00f3pez-Picazo JM, Lozano MD, Toledo G, Thunnissen FB, et al. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Clin Cancer Res. 2004;10(11):3639\u201349. https:\/\/doi.org\/10.1158\/1078-0432.CCR-03-0338.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3450_CR59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ijc.10736","volume":"102","author":"C Denkert","year":"2002","unstructured":"Denkert C, Schmitt WD, Berger S, Reles A, Pest S, Siegert A, et al. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma. Int J Cancer. 2002;102(5):507\u201313. https:\/\/doi.org\/10.1002\/ijc.10736.","journal-title":"Int J Cancer"},{"issue":"24","key":"3450_CR60","doi-asserted-by":"publisher","first-page":"7498","DOI":"10.1158\/0008-5472.CAN-14-1541","volume":"74","author":"D Candas","year":"2014","unstructured":"Candas D, Lu CL, Fan M, Chuang FY, Sweeney C, Borowsky AD, Li JJ. Mitochondrial MKP-1 is a target for therapy-resistant HER2-positive breast cancer cells. Cancer Res. 2014;74(24):7498\u2013509. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-1541.","journal-title":"Cancer Res"},{"issue":"1","key":"3450_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1006\/bbr","volume":"250","author":"YJ Bang","year":"1998","unstructured":"Bang YJ, Kwon JH, Kang SH, Kim JW, Yang YC. Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. Biochem Biophys Res Commun. 1998;250(1):43\u20137. https:\/\/doi.org\/10.1006\/bbr.","journal-title":"Biochem Biophys Res Commun"},{"issue":"55","key":"3450_CR62","doi-asserted-by":"publisher","first-page":"94028","DOI":"10.18632\/oncotarget.21578","volume":"8","author":"X Kang","year":"2017","unstructured":"Kang X, Li M, Zhu H, Lu X, Miao J, Du S, et al. DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial\u2013mesenchymal transition. Oncotarget. 2017;8(55):94028\u201341. https:\/\/doi.org\/10.18632\/oncotarget.21578.","journal-title":"Oncotarget"},{"issue":"3","key":"3450_CR63","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.bbrc.2020.05.107","volume":"528","author":"P Ratsada","year":"2020","unstructured":"Ratsada P, Hijiya N, Hidano S, Tsukamoto Y, Nakada C, Uchida T, et al. DUSP4 is involved in the enhanced proliferation and survival of DUSP4-overexpressing cancer cells. Biochem Biophys Res Commun. 2020;528(3):586\u201393. https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.107.","journal-title":"Biochem Biophys Res Commun"},{"key":"3450_CR64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2017.10.007","volume":"412","author":"QN Wu","year":"2018","unstructured":"Wu QN, Liao YF, Lu YX, Wang Y, Lu JH, Zeng ZL, et al. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance. Cancer Lett. 2018;412:243\u201355. https:\/\/doi.org\/10.1016\/j.canlet.2017.10.007.","journal-title":"Cancer Lett"},{"issue":"7","key":"3450_CR65","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.3390\/ijms20071626","volume":"20","author":"M Jim\u00e9nez-Mart\u00ednez","year":"2019","unstructured":"Jim\u00e9nez-Mart\u00ednez M, Stamatakis K, Fresno M. The dual-specificity phosphatase 10 (DUSP10): its role in cancer, inflammation, and immunity. Int J Mol Sci. 2019;20(7):1626. https:\/\/doi.org\/10.3390\/ijms20071626.","journal-title":"Int J Mol Sci"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03450-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03450-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03450-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:00:49Z","timestamp":1791460849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03450-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":65,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3450"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03450-z","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"330"}}